Kyowa Hakko Kirin Co., Ltd Company Review & Valuation KYKOF
About Kyowa Hakko Kirin Co., Ltd
Kyowa Hakko Kirin Co., Ltd., a research-based life sciences company, manufactures and markets pharmaceuticals and bio-chemicals worldwide. Its products include ABSTRAL, cancer pain; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; ESPO, a glycoprotein and human erythropoietin; NESP/Aranesp, an erythropoiesis stimulating agent; GRAN, a human colony-stimulating factor; and Peglasta/Neulasta for chemotherapy-induced febrile neutropenia. The company's products also comprise LEUNASE for acute lymphoblastic leukemia; Mitomycin-C is an anticancer antibiotic; PecFent, a nasally administrated spray; and REGPARA, a new class of agent for the treatment of secondary hyperparathyroidism. In addition, it offers Romiplate/Nplate, a genetically recombinant protein, which stimulates platelet production through the stimulation of thrombopoietin receptors; and SANCUSO, a treatment for nausea and vomiting. The company was founded in 1949 and is headquartered in Tokyo, Japan. Kyowa Hakko Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.
- Drug Manufacturers - Major
- Tokyo, Japan
Primary Stock Exchange Listings